BRIEF-Janssen Pharm says FDA granted Ibrutinib breakthrough therapy designation for CGVHD
June 29, 2016 at 11:00 AM EDT
* Janssen pharmaceutical companies says FDA also granted therapy orphan drug designation for CGVHD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.